X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (185) 185
hematology (107) 107
female (102) 102
index medicus (101) 101
peripheral vascular disease (83) 83
adult (71) 71
middle aged (65) 65
male (57) 57
risk factors (47) 47
aged (45) 45
thrombosis (40) 40
venous thromboembolism (38) 38
thromboembolism (36) 36
venous thrombosis (36) 36
hematology, oncology and palliative medicine (34) 34
pregnancy (31) 31
coagulation (30) 30
risk (28) 28
heparin (25) 25
tissue factor pathway inhibitor (24) 24
lipoproteins - metabolism (22) 22
research (22) 22
anticoagulants - therapeutic use (21) 21
tissue factor (21) 21
anticoagulants (20) 20
case-control studies (20) 20
factor pathway inhibitor (20) 20
lipoproteins - blood (20) 20
treatment outcome (19) 19
lipoproteins - genetics (18) 18
analysis (17) 17
medicine, general & internal (17) 17
deep-vein thrombosis (16) 16
factor-xa (16) 16
women (16) 16
animals (15) 15
blood coagulation - drug effects (15) 15
clinical neurology (15) 15
disease (15) 15
heparin - pharmacology (15) 15
hormone replacement therapy (15) 15
venous thrombosis - etiology (15) 15
blood-coagulation (14) 14
coagulation inhibitor (14) 14
coagulation inhibitors (14) 14
health aspects (14) 14
time factors (14) 14
acute disease (13) 13
anticoagulants - administration & dosage (13) 13
cancer (13) 13
estrogen (13) 13
expression (13) 13
hemostasis (13) 13
medical research (13) 13
prevention (13) 13
recurrence (13) 13
tfpi (13) 13
thrombin (13) 13
adolescent (12) 12
aged, 80 and over (12) 12
genetic aspects (12) 12
norway (12) 12
postthrombotic syndrome (12) 12
practice guidelines as topic (12) 12
research article (12) 12
thromboplastin - metabolism (12) 12
abridged index medicus (11) 11
blood clot (11) 11
double-blind (11) 11
double-blind method (11) 11
follow-up studies (11) 11
gene expression (11) 11
molecular-weight heparin (11) 11
physiological aspects (11) 11
blood coagulation (10) 10
extrinsic pathway (10) 10
factor vii - antagonists & inhibitors (10) 10
factor-v-leiden (10) 10
mutation (10) 10
obstetrics & gynecology (10) 10
plasma (10) 10
pregnant women (10) 10
prevalence (10) 10
protein c (10) 10
pulmonary embolism (10) 10
thromboplastin - antagonists & inhibitors (10) 10
activation (9) 9
administration, oral (9) 9
biochemistry & molecular biology (9) 9
bleeding (9) 9
breast cancer (9) 9
drug therapy (9) 9
epi (9) 9
factor v - genetics (9) 9
factor xa inhibitors (9) 9
fibrinolysis (9) 9
hormone replacement therapy - adverse effects (9) 9
hormone therapy (9) 9
internal medicine (9) 9
patients (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis Research, ISSN 0049-3848, 12/2019, Volume 184, pp. 62 - 66
The Villalta scale is currently the recommended tool for diagnosing post-thrombotic syndrome (PTS) in clinical studies, but there is concern that the... 
Deep vein thrombosis | Chronic venous disease | Clinical tool | Comorbidity | Post-thrombotic syndrome | Classification
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2019, Volume 17, Issue 10, pp. 1707 - 1714
Summary Background The Villalta scale is recommended for diagnosing and grading of postthrombotic syndrome (PTS) in clinical studies, but with limitations in... 
chronic venous disease | deep vein thrombosis | postthrombotic syndrome | qualitative research | clinical tool | Medical personnel | Pain | Ulcers | Leg ulcers | Skin | Patients | Thrombosis
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3777 - 3777
Abstract The F7 gene mutations p.Q160R and p.A354V-p.P464Hfs are associated with very low factor VII (FVII) activity and antigen levels and a bleeding... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2511 - 2511
Abstract Introduction: ITP is an acquired autoimmune disorder characterized by isolated thrombocytopenia and an increased risk of bleeding. Paradoxically, ITP... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2452 - 2452
Abstract Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. Cell trafficking and homing of CLL cells play a critical role in... 
Journal Article
Thrombosis Research, ISSN 0049-3848, 04/2012, Volume 129, Issue 1, pp. S97 - S100
Platelet factor 4 (CXCL4-PF4) is a chemokine that binds to and neutralizes heparin and other negatively charged proteoglycans, but is also involved in... 
Chemokine | Thrombocytopenia | Heparin | Thrombosis | Heparin-induced thrombocytopenia | CXCL4 | Development and progression | Anticoagulants (Medicine) | Glycosaminoglycans | Cancer
Journal Article
Thrombosis Research, ISSN 0049-3848, 12/2019, Volume 184, pp. 1 - 7
Women develop cardiovascular disease (CVD) approximately 7–10 years later than men, but progress with similar risk after menopause. Recent studies suggest that... 
Hormone replacement therapy | Venous thrombosis | Thrombogenicity | Plasma lipids | Lp(a)
Journal Article
Thrombosis Research, ISSN 0049-3848, 04/2018, Volume 164, pp. 110 - 115
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2018, Volume 118, Issue 4, pp. 664 - 675
Abstract Congenital factor (F) VII deficiency is a bleeding disorder caused by a heterogeneous pattern of mutations in the F7 gene. Protein misfolding due to... 
Coagulation and Fibrinolysis | factor VII deficiency | unfolded protein response | endoplasmic reticulum stress | ER STRESS | QUALITY-CONTROL | MUTATION A294V | GENE | FACTOR-LIKE DOMAIN | COAGULATION | PERIPHERAL VASCULAR DISEASE | FVII DEFICIENCY | SECRETION | HEMATOLOGY | TISSUE FACTOR | MANIFESTATIONS
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 07/2017, Volume 43, Issue 5, pp. 500 - 504
Journal Article
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, ISSN 0029-2001, 06/2016, Volume 136, Issue 10, pp. 898 - 899
Journal Article
Platelets, ISSN 0953-7104, 2018, pp. 1 - 5
Factor Xa inhibitors are safe and effective alternatives to warfarin, but several studies indicate that rivaroxaban may cause a different risk profile for... 
Platelet aggregation | rivaroxaban | von Willebrand factor | P-selectin
Journal Article
Platelets, ISSN 0953-7104, 07/2019, pp. 1 - 7
Immune thrombocytopenia (ITP) patients have thrombocytopenia and increased bleeding risk, but, conversely, they also have increased thrombotic risk which... 
Journal Article
Tidsskrift for den Norske Laegeforening, ISSN 0029-2001, 2016, Volume 136, Issue 12-13, p. 1062
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.